slides · global inventory
Title
Component collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 303,780
Current window 221,941-221,970
Pages 10,126
Rows per page 30
Component
221,941-221,970 of 303,780
17
The slide uses a classic 'problem vs. solution' or 'market gap vs. strategic imperative' structure.Theravance Biopharma | Results Presentation Deck | 35 slides · Theravance Biopharma
Conference presentation Investor relations Beat · SatisfactionLoop · Cost Of Inaction1 hit
18
Theravance Biopharma | Results Presentation Deck | 35 slidesTheravance Biopharma | Results Presentation Deck | 35 slides · Theravance Biopharma
Conference presentation Investor relations Beat · Satisfaction1 hit
19
Includes GAAP and non-GAAP financial measures.Theravance Biopharma | Results Presentation Deck | 35 slides · Theravance Biopharma
Conference presentation Investor relations Beat · Action1 hit
20
The slide provides a standard financial reconciliation table.Theravance Biopharma | Results Presentation Deck | 35 slides · Theravance Biopharma
Conference presentation Investor relations Beat · Action1 hit
24
The table displays projected royalties, net sales, and milestone payments from 2023 to 2026.Theravance Biopharma | Results Presentation Deck | 35 slides · Theravance Biopharma
Conference presentation Investor relations Beat · Action1 hit
26
Theravance Biopharma | Results Presentation Deck | 35 slidesTheravance Biopharma | Results Presentation Deck | 35 slides · Theravance Biopharma
Conference presentation Investor relations 1 hit
27
Standard pharmaceutical product disclosure slide.Theravance Biopharma | Results Presentation Deck | 35 slides · Theravance Biopharma
Conference presentation Investor relations 1 hit
28
Includes a footnote referencing market research methodology.Theravance Biopharma | Results Presentation Deck | 35 slides · Theravance Biopharma
Conference presentation Investor relations 1 hit
29
Theravance Biopharma | Results Presentation Deck | 35 slidesTheravance Biopharma | Results Presentation Deck | 35 slides · Theravance Biopharma
Conference presentation Investor relations 1 hit
30
Includes definitions for COPD, nOH, and PTE in the footer.Theravance Biopharma | Results Presentation Deck | 35 slides · Theravance Biopharma
Conference presentation Investor relations 1 hit
31
The slide uses a mathematical equation format to explain the revenue recognition process.Theravance Biopharma | Results Presentation Deck | 35 slides · Theravance Biopharma
Conference presentation Investor relations 1 hit
32
The slide uses a split-panel layout to compare two distinct deal structures.Theravance Biopharma | Results Presentation Deck | 35 slides · Theravance Biopharma
Conference presentation Investor relations 1 hit
33
This slide serves as a reference or bibliography page for a conference presentation.Theravance Biopharma | Results Presentation Deck | 35 slides · Theravance Biopharma
Conference presentation Investor relations 1 hit
34
Uses a before-after framing to justify a strategic pivot in clinical trial focus.Theravance Biopharma | Results Presentation Deck | 35 slides · Theravance Biopharma
Conference presentation Investor relations Loop · Before After1 hit
35
Theravance Biopharma | Results Presentation Deck | 35 slidesTheravance Biopharma | Results Presentation Deck | 35 slides · Theravance Biopharma
Conference presentation Investor relations Loop · Before After1 hit
02
UBS | Fixed Income Presentation Deck | 44 slidesUBS | Fixed Income Presentation Deck | 44 slides · UBS
Conference presentation Investor relations Beat · Attention1 hit
03
UBS | Fixed Income Presentation Deck | 44 slidesUBS | Fixed Income Presentation Deck | 44 slides · UBS
Conference presentation Investor relations Beat · Attention1 hit
04
UBS | Fixed Income Presentation Deck | 44 slidesUBS | Fixed Income Presentation Deck | 44 slides · UBS
Conference presentation Investor relations Beat · Attention1 hit
05
UBS | Fixed Income Presentation Deck | 44 slidesUBS | Fixed Income Presentation Deck | 44 slides · UBS
Conference presentation Investor relations Beat · NeedLoop · Cost Of Inaction1 hit
07
UBS | Fixed Income Presentation Deck | 44 slidesUBS | Fixed Income Presentation Deck | 44 slides · UBS
Conference presentation Investor relations Beat · NeedLoop · Cost Of Inaction1 hit
08
The slide uses grouped bar charts to compare UBS and Credit Suisse performance metrics.UBS | Fixed Income Presentation Deck | 44 slides · UBS
Conference presentation Investor relations Beat · NeedLoop · Cost Of Inaction1 hit
09
The slide details the composition of the Non-core and Legacy (NCL) perimeter, highlighting the wind-down of Credit Suisse assets.UBS | Fixed Income Presentation Deck | 44 slides · UBS
Conference presentation Investor relations Beat · NeedLoop · Cost Of Inaction1 hit
10
The chart shows a projected decline in RWA from 55bn in 2Q23 to 28bn in YE26.UBS | Fixed Income Presentation Deck | 44 slides · UBS
Conference presentation Investor relations Beat · NeedLoop · Cost Of Inaction1 hit
11
The slide uses a logic flow from strategic levers (left) to financial targets (right).UBS | Fixed Income Presentation Deck | 44 slides · UBS
Conference presentation Investor relations Beat · SatisfactionLoop · Hypothesis Test1 hit
12
The chart shows a bridge from current state to 2026 exit rate via four strategic levers.UBS | Fixed Income Presentation Deck | 44 slides · UBS
Conference presentation Investor relations Beat · SatisfactionLoop · Hypothesis Test1 hit
14
The chart illustrates the impact of the Credit Suisse acquisition on 2Q23 results.UBS | Fixed Income Presentation Deck | 44 slides · UBS
Conference presentation Investor relations Beat · SatisfactionLoop · Hypothesis Test1 hit
15
The slide uses two waterfall charts to explain the financial impact of the Credit Suisse acquisition.UBS | Fixed Income Presentation Deck | 44 slides · UBS
Conference presentation Investor relations Beat · SatisfactionLoop · Hypothesis Test1 hit
16
The slide uses stacked bar charts to illustrate capital structure in absolute terms (bn) and relative terms (%), comparing current status to regulatory requirements.UBS | Fixed Income Presentation Deck | 44 slides · UBS
Conference presentation Investor relations Beat · SatisfactionLoop · Hypothesis Test1 hit
17
The chart shows the reduction of drawn SNB facilities from 120bn to 0 between March and August 2023.UBS | Fixed Income Presentation Deck | 44 slides · UBS
Conference presentation Investor relations Beat · SatisfactionLoop · Hypothesis Test1 hit
18
The chart uses a waterfall-like structure to bridge divisional performance to total group performance, highlighting the impact of integration-related expenses.UBS | Fixed Income Presentation Deck | 44 slides · UBS
Conference presentation Investor relations Beat · SatisfactionLoop · Hypothesis Test1 hit